Schrodinger PE Ratio 2019-2024 | SDGR

Current and historical p/e ratio for Schrodinger (SDGR) from 2019 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Schrodinger PE ratio as of February 06, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Schrodinger PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-02-05 26.15 0.00
2024-09-30 18.55 $-2.34 0.00
2024-06-30 19.34 $-2.68 0.00
2024-03-31 27.00 $-1.88 0.00
2023-12-31 35.80 $0.63 56.83
2023-09-30 28.27 $0.56 50.48
2023-06-30 49.92 $0.86 58.05
2023-03-31 26.33 $0.13 202.54
2022-12-31 18.69 $-2.10 0.00
2022-09-30 24.98 $-2.14 0.00
2022-06-30 26.41 $-2.07 0.00
2022-03-31 34.12 $-1.89 0.00
2021-12-31 34.83 $-1.41 0.00
2021-09-30 54.68 $-1.16 0.00
2021-06-30 75.61 $-0.62 0.00
2021-03-31 76.29 $-0.18 0.00
2020-12-31 79.18 $-0.52 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.827B $0.217B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.870B 55.80
Tempus AI (TEM) United States $9.036B 0.00
Hims & Hers Health (HIMS) United States $8.145B 207.11
Inspire Medical Systems (INSP) United States $5.799B 180.84
IRhythm Technologies (IRTC) United States $3.407B 0.00
Privia Health (PRVA) United States $2.742B 228.50
Enovis (ENOV) United States $2.671B 17.80
Azenta (AZTA) United States $2.470B 131.83
Clover Health Investments (CLOV) United States $2.200B 0.00
Omnicell (OMCL) United States $2.084B 68.17
10x Genomics (TXG) United States $1.816B 0.00
Phreesia (PHR) United States $1.654B 0.00
Butterfly Network (BFLY) United States $0.850B 0.00
Standard BioTools (LAB) United States $0.577B 0.00
Talkspace (TALK) United States $0.524B 0.00
Fulgent Genetics (FLGT) United States $0.509B 0.00
TruBridge (TBRG) United States $0.370B 107.91
Nyxoah SA (NYXH) Belgium $0.368B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.229B 0.00
Pulmonx (LUNG) United States $0.224B 0.00
American Well (AMWL) United States $0.165B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
EUDA Health Holdings (EUDA) Singapore $0.087B 0.00
P3 Health Partners (PIII) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
CareCloud (CCLD) United States $0.056B 0.00
111 (YI) China $0.050B 0.00
SHL Telemedicine (SHLT) Israel $0.047B 0.00
Outset Medical (OM) United States $0.043B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00